Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

: encompasses several species of free-living ameba encountered commonly throughout the environment. Unfortunately, these species of ameba can cause opportunistic infections that result in keratitis, granulomatous amebic encephalitis, and occasionally systemic infection.: This review discusses relevant literature found through PubMed and Google scholar published as of January 2021. The review summarizes current common keratitis treatments, drug discovery methodologies available for screening potential anti- compounds, and the anti- activity of various azole antifungal agents.: While several biguanide and diamidine antimicrobial agents are available to clinicians to effectively treat keratitis, no singular treatment can effectively treat every keratitis case.Efforts to identify new anti-Acanthamoeba agents include trophozoite cell viability assays, which are amenable to high-throughput screening. Cysticidal assays remain largely manual and would benefit from further automation development. Additionally, the existing literature on the effectiveness of various azole antifungal agents for treating keratitis is incomplete or contradictory, suggesting the need for a systematic review of all azoles against different pathogenic strains.